GenAI may excelling in some areas but fail in others, complicating the business case. CIOs often underestimate costs, which can scale by 500%-1000%. Productivity is a key benefit but hard to prove to CFOs. Should you invest in chat-style GenAI for 100K employees or near-custom AI for 50 R&D staff? Join our session to master cost scaling, value harvesting beyond productivity, and creating a portfolio of GenAI investment options.